Medicare 2027 Negotiating Class: Austedo, Linzess, Xifaxan May Face Generic, OTC Price Comparators

 
• By Cathy Kelly
  
Will generic or OTC alternatives lower the bar for Medicare negotiated prices? (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Medicare

More from Geography